Analysis of FK506‑mediated functional recovery and neuroprotection in a rat model of spinal cord injury indicates that EGF is modulated in astrocytes

Cai,Jun; Sun,Yu; Yin,Zaoyang; Wang,Daode; Shi,Kun; Fu,Yuxuan; Cao,Xiaojian; Ge,Yingbin

doi:10.3892/etm.2018.6283

Analysis of FK506‑mediated functional recovery and neuroprotection in a rat model of spinal cord injury indicates that EGF is modulated in astrocytes

Authors:
- Jun Cai
- Yu Sun
- Zaoyang Yin
- Daode Wang
- Kun Shi
- Yuxuan Fu
- Xiaojian Cao
- Yingbin Ge
View Affiliations

Affiliations: Department of Orthopedics, Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Department of Orthopedics, Subei People's Hospital, Yangzhou, Jiangsu 225001, P.R. China, Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, Department of Physiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Published online on: June 8, 2018 https://doi.org/10.3892/etm.2018.6283
Pages: 501-510
Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to evaluate whether the application of tacrolimus (FK506) could improve functional recovery in spinal cord injury (SCI) rat models by activating astrocytes, and to further investigate the underlying mechanisms of this action. Male Sprague‑Dawley rats (n=56) were used to establish moderate SCI models, which were induced at the T10 spinal segment by dropping a 10‑g weight from a height of 25 mm using a New York University Impactor device. The rats were randomly separated into the FK506 or control group (n=28 per group). Rats were treated with FK506 (0.5 mg/kg) or saline intravenously 30 min after sustaining the injury. Functional recovery was evaluated over 42 days following the injury, and epidermal growth factor (EGF) levels were detected. The astrocytes were treated with FK506 in vitro, and the EGF mRNA and protein expression levels were analyzed using reverse transcription‑quantitative polymerase chain reaction and ELISA, respectively. DNA microarray analysis was also performed to evaluate the genes in astrocytes. Rats in the FK506 group had improved locomotor functional recovery compared with those of control group. Furthermore, FK506 upregulated EGF expression of astrocytes both in vivo and in vitro. Subsequent to treatment with FK506‑conditioned medium (CM), the length of neuronal cells increased 61.06% on the first day, and increased 56.4% on the third day compared with those of C‑CM group. Furthermore, addition of anti‑EGF neutralizing antibodies could interrupt the promotion of neurite outgrowth by FK506‑CM. The present study indicates that astrocytes have an important role as mediators of FK506‑improved spinal cord function recovery, and this partially clarifies the role of cell‑cell interaction through modulating EGF in this process.

View Figures

View References

1	Ibarra A and Martiñón S: Pharmacological approaches to induce neuroregeneration in spinal cord injury: An overview. Curr Drug Discov Technol. 6:82–90. 2009. View Article : Google Scholar : PubMed/NCBI
2	Baptiste DC and Fehlings MG: Update on the treatment of spinal cord injury. Prog Brain Res. 161:217–233. 2007. View Article : Google Scholar : PubMed/NCBI
3	Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB and Sofroniew MV: Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci. 24:2143–2155. 2004. View Article : Google Scholar : PubMed/NCBI
4	Davies S, Shih CH, Noble M, Mayer-Proschel M, Davies JE and Proschel C: Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One. 6:e173282011. View Article : Google Scholar : PubMed/NCBI
5	Staatz CE and Tett SE: Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 43:623–653. 2004. View Article : Google Scholar : PubMed/NCBI
6	Klettner A and Herdegen T: FK506 and its analogs-therapeutic potential for neurological disorders. Curr Drug Targets CNS Neurol Disord. 2:153–162. 2003. View Article : Google Scholar : PubMed/NCBI
7	Sosa I, Reyes O and Kuffler D: Immunosuppressants: Neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions. Exp Neurol. 195:7–15. 2005. View Article : Google Scholar : PubMed/NCBI
8	Wildering WC, Hermann PM and Bulloch AG: Lymnaea epidermal growth factor promotes axonal regeneration in CNS organ culture. J Neurosci. 21:9345–9354. 2001. View Article : Google Scholar : PubMed/NCBI
9	Liberto CM, Albrecht PJ, Herx LM, Yong VW and Levison SW: Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem. 89:1092–1100. 2004. View Article : Google Scholar : PubMed/NCBI
10	Kuh SU, Cho YE, Yoon DH, Kim KN and Ha Y: Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien). 147:985–992. 2005. View Article : Google Scholar : PubMed/NCBI
11	Young W: Spinal cord regeneration. Science. 273:4511996. View Article : Google Scholar : PubMed/NCBI
12	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
13	Zhang A, Zhang J, Sun P, Yao C, Su C, Sui T, Huang H, Cao X and Ge Y: EIF2alpha and caspase-12 activation are involved in oxygen-glucose-serum deprivation/restoration-induced apoptosis of spinal cord astrocytes. Neurosci Lett. 478:32–36. 2010. View Article : Google Scholar : PubMed/NCBI
14	Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, et al: The transcriptional program in the response of human fibroblasts to serum. Science. 283:83–87. 1999. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Liu N, Li H, Liu K, Yu J, Cheng M, De W, Liu J, Shi S, He Y and Zhao J: Differential expression of genes and proteins associated with wool follicle cycling. Mol Biol Rep. 41:5343–5349. 2014. View Article : Google Scholar : PubMed/NCBI
17	Cai J, Zhao XL, Liu AW, Nian H and Zhang SH: Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine. 18:366–373. 2011. View Article : Google Scholar : PubMed/NCBI
18	Gezginci-Oktayoglu S, Karatug A and Bolkent S: The relation among NGF, EGF and insulin is important for triggering pancreatic β cell apoptosis. Diabetes Metab Res Rev. 28:654–662. 2012. View Article : Google Scholar : PubMed/NCBI
19	Han SS, Kang DY, Mujtaba T, Rao MS and Fischer I: Grafted lineage-restricted precursors differentiate exclusively into neurons in the adult spinal cord. Exp Neurol. 177:360–375. 2002. View Article : Google Scholar : PubMed/NCBI
20	Gomes FC, Maia CG, de Menezes JR and Neto VM: Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation. Glia. 25:247–255. 1999. View Article : Google Scholar : PubMed/NCBI
21	Stipursky J and Gomes FC: TGF-beta1/SMAD signaling induces astrocyte fate commitment in vitro: Implications for radial glia development. Glia. 55:1023–1033. 2007. View Article : Google Scholar : PubMed/NCBI
22	Spohr E TC, Dezonne RS, Rehen SK and Gomes FC: Astrocytes treated by lysophosphatidic acid induce axonal outgrowth of cortical progenitors through extracellular matrix protein and epidermal growth factor signaling pathway. J Neurochem. 119:113–123. 2011. View Article : Google Scholar : PubMed/NCBI
23	Voda J, Yamaji T and Gold BG: Neuroimmunophilin ligands improve functional recovery and increase axonal growth after spinal cord hemisection in rats. J Neurotrauma. 22:1150–1161. 2005. View Article : Google Scholar : PubMed/NCBI
24	Yeh C, Bowers D and Hadlock TA: Effect of FK506 on functional recovery after facial nerve injury in the rat. Arch Facial Plast Surg. 9:333–339. 2007. View Article : Google Scholar : PubMed/NCBI
25	López-Vales R, García-Alías G, Forés J, Udina E, Gold BG, Navarro X and Verdú E: FK506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J Neurosci Res. 81:827–836. 2005. View Article : Google Scholar : PubMed/NCBI
26	Udina E, Ceballos D, Verdú E, Gold BG and Navarro X: Bimodal dose-dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve. 26:348–355. 2002. View Article : Google Scholar : PubMed/NCBI
27	Gold BG, Densmore V, Shou W, Matzuk MM and Gordon HS: Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther. 289:1202–1210. 1999.PubMed/NCBI
28	Buffo A, Rolando C and Ceruti S: Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol. 79:77–89. 2010. View Article : Google Scholar : PubMed/NCBI
29	Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH and Sofroniew MV: Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 23:297–308. 1999. View Article : Google Scholar : PubMed/NCBI
30	Szydlowska K, Gozdz A, Dabrowski M, Zawadzka M and Kaminska B: Prolonged activation of ERK triggers glutamate-induced apoptosis of astrocytes: Neuroprotective effect of FK506. J Neurochem. 113:904–918. 2010. View Article : Google Scholar : PubMed/NCBI
31	Szydlowska K, Zawadzka M and Kaminska B: Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo. J Neurochem. 99:965–975. 2006. View Article : Google Scholar : PubMed/NCBI
32	Kahraman S, Bambrick LL and Fiskum G: Effects of FK506 and cyclosporin a on calcium ionophore-induced mitochondrial depolarization and cytosolic calcium in astrocytes and neurons. J Neurosci Res. 89:1973–1978. 2011. View Article : Google Scholar : PubMed/NCBI
33	Wong RW and Guillaud L: The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev. 15:147–156. 2004. View Article : Google Scholar : PubMed/NCBI
34	Fricker-Gates RA, Winkler C, Kirik D, Rosenblad C, Carpenter MK and Bjorklund A: EGF infusion stimulates the proliferation and migration of embryonic progenitor cells transplanted in the adult rat striatum. Exp Neurol. 165:237–247. 2000. View Article : Google Scholar : PubMed/NCBI
35	Yamada M, Ikeuchi T and Hatanaka H: The neurotrophic action and signalling of epidermal growth factor. Prog Neurobiol. 51:19–37. 1997. View Article : Google Scholar : PubMed/NCBI
36	Goldshmit Y, Greenhalgh CJ and Turnley AM: Suppressor of cytokine signalling-2 and epidermal growth factor regulate neurite outgrowth of cortical neurons. Eur J Neurosci. 20:2260–2266. 2004. View Article : Google Scholar : PubMed/NCBI
37	Martinez R and Gomes FC: Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins. J Biol Chem. 277:49311–49318. 2002. View Article : Google Scholar : PubMed/NCBI
38	Xiang YY, Dong H, Wan Y, Li J, Yee A, Yang BB and Lu WY: Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem. 281:19358–19368. 2006. View Article : Google Scholar : PubMed/NCBI
39	Zawadzka M and Kaminska B: Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol Cell Neurosci. 22:202–209. 2003. View Article : Google Scholar : PubMed/NCBI